论文部分内容阅读
临床医生一般通过哪些渠道获得有关新药的信息？ 又有哪些主观与客观因素影响着医生倾向于利用药品的某种或某些种信息来源，而在处方中使用该药？这都是制药厂家及其销售代表和药商们关心的问题。本文基于“合理行动理论”并略加改良，挑选一组专业较为均一的医生群体作为对象，采取问卷调查方式，对这些问题进行了一项优于既往各类似研究的分析探讨。所获结果对于药商们在临床医生中如何扩大销售量及选择合理的市场信息均有启发作用
What are the channels through which clinicians generally obtain information about new drugs? What subjective and objective factors influence the doctor’s tendency to use one or more sources of information for drugs and use the drug in prescriptions? This is a concern for pharmaceutical manufacturers, their sales representatives and drug dealers. This article is based on “reasonable action theory” and slightly improved, picking a group of doctors with relatively uniform professional groups as the object, adopting a questionnaire survey method, and conducting an analysis of these issues better than previous similar studies. The results obtained are instructive for how drug dealers can increase sales and choose reasonable market information among clinicians.